Back
Speaker illustration

undefined undefined undefined

Presentations Articles

Mechanistic basis for differential effects of interatrial shunt treatment in HFrEF vs HFpEF

Event: ESC Congress 2025

Topic: Heart Failure

Session: Shunting forward: new insights, mechanisms, and the future of interatrial shunt devices in heart failure

Access
Like
Thumbnail

RELIEVE-HF Trial Mechanisms for Differential Clinical Outcomes

Event: Heart Failure 2024

Topic: Pathophysiology

Session: Late breaking clinical trials: devices

Access
Like
Thumbnail

BeAT-HF: long-term safety profile and outcomes

Event: ESC Congress 2023

Topic: Chronic Heart Failure

Session: Baroreflex activation therapy for HFrEF patients: long-term data and real-world experience

Access
Like
Thumbnail

Insights into the Effects of the COVID-19 Pandemic: Comprehensive Analysis from the GUIDE-HF Trial

Event: ESC Congress 2021 - The Digital Experience

Topic: Treatment

Session: Late Breaking Trials - COVID-19

Access
Like
Thumbnail

Overview of neuromodulation devices in HFrEF.

Event: ESC Congress 2021 - The Digital Experience

Topic: Chronic Heart Failure

Session: Neuromodulation for the management of patients with HFrEF: the present and the future

Access
Like
Thumbnail

Fibrosis is the bad guy

Event: Heart Failure 2018

Topic: Cardiac Biology and Physiology

Session: HFpEF – Still an unsolved enigma?

Access
Like
Thumbnail

Effect of sacubitril/valsartan on plasma biomarkers that reflect extracellular matrix regulatory mechanisms and collagen synthesis in patients with heart failure and reduced ejection fraction.

Event: ESC Congress 2017

Topic: Heart failure, other

Session: Can we teach heart failure drugs new tricks?

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources